Alpha 2.0
Login Register
» Articles » PMID: 38573285

Diagnostic Utility of SGLT2 Inhibitors to Facilitate Myocardial Glucose Suppression During Evaluation of Myocardial Inflammation

Overview
Journal JACC Cardiovasc Imaging
Publisher Elsevier
Specialties Cardiology & Vascular Diseases
Radiology
Date 2024 Apr 4
PMID 38573285
Authors
Senthil Selvaraj
Mahesh K Vidula
Brian Claggett
Chaitanya Rojulpote
Abhijit Bhattaru
Caitlin B Clancy
Milton Rossman
Daniel A Pryma
Lee R Goldberg
Paco E Bravo
Affiliations
Soon will be listed here.
Citing Articles

Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction.

Selvaraj S, Patel S, Sauer A, McGarrah R, Jones P, Kwee L Circ Heart Fail. 2024; 17(11):e011980.

PMID: 39421941 PMC: 11634023. DOI: 10.1161/CIRCHEARTFAILURE.124.011980.

How to prepare a patient for 18F-fluorodeoxyglucose positron emission tomography imaging to assess myocardial inflammation.

Selvaraj S, Bravo P J Nucl Cardiol. 2024; 38:101888.

PMID: 38830570 PMC: 11366490. DOI: 10.1016/j.nuclcard.2024.101888.

References
1.
Lauritsen K, Nielsen B, Tolbod L, Johannsen M, Hansen J, Hansen T . SGLT2 Inhibition Does Not Affect Myocardial Fatty Acid Oxidation or Uptake, but Reduces Myocardial Glucose Uptake and Blood Flow in Individuals With Type 2 Diabetes: A Randomized Double-Blind, Placebo-Controlled Crossover Trial. Diabetes. 2020; 70(3):800-808. DOI: 10.2337/db20-0921. View
2.
Selvaraj S, Margulies K, Dugyala S, Schubert E, Tierney A, Arany Z . Comparison of Exogenous Ketone Administration Versus Dietary Carbohydrate Restriction on Myocardial Glucose Suppression: A Crossover Clinical Trial. J Nucl Med. 2021; 63(5):770-776. PMC: 9051592. DOI: 10.2967/jnumed.121.262734. View
3.
Vidula M, Kelly D, Arany Z, Margulies K, Shah S, Cappola T . Metabolomic Signatures of Myocardial Glucose Uptake on Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography. JACC Basic Transl Sci. 2023; 7(12):1264-1266. PMC: 9831924. DOI: 10.1016/j.jacbts.2022.09.011. View
4.
Selvaraj S, Fu Z, Jones P, Kwee L, Windsor S, Ilkayeva O . Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF. Circulation. 2022; 146(11):808-818. PMC: 9474658. DOI: 10.1161/CIRCULATIONAHA.122.060402. View
5.
Osborne M, Hulten E, Murthy V, Skali H, Taqueti V, Dorbala S . Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation. J Nucl Cardiol. 2016; 24(1):86-99. PMC: 5841447. DOI: 10.1007/s12350-016-0502-7. View